Rapamycin, locally known as Rapamune serves a lot of purposes in the medical industry. The drug is used to prevent rejection during organ transplant, coating coronary stents, treating lung disease, and the biggest being the role it plays in cancer research management. Initially, Rapamycin was used as anti-fungal until research showed that it has excellent immunosuppressive and antiproliferative properties. Further, the drug has found a new use after Mikhail Blagosklonny conducted a study and found it to have the ability to prolong life. Mikhail is a professor of Oncology. He is based at Rosewell Park Cancer Institute in Buffalo, New York. He has researched on cancer and its therapies. Recently, Blagosklonny is conducting extensive research on the subject of aging.Rapamycin is among the best drugs in the medical industry due to its contribution to the curing of several diseases. It is used as an immunosuppressant during an organ transplant. Naturally, the body principle action is to reject new organs. However, administration of the above drug as an anti-rejection enhances compatibility. Most importantly, it has lower toxic levels as compared to other drugs.
Rapamycin is also used for treating hemolytic-uremic syndrome, a disease that is as a result of anemia and kidney failure. Kidney transplant requires the use of Rapamycin to reduce the chance of rejection. The drug work wonders when it comes to the treatment of cancer. Its anti-proliferative properties enhance the immune system enabling the body to respond towards the tumors. It also plays a role in tumor regression.Additionally, the presence of mTOR inhibitors in the drug makes it suitable for suppressing tuberous sclerosis. Studies have shown tumor re-growth after patients were discontinued from the medication. On the other hand, people ailing from TSC are mostly affected by facial angiofibromas. The rash is treated cosmetically using lasers or dermabrasion. However, Rapamycin is the best drug to address the outbreak. According to Mikhail Blagosklonny, Rapamycin causes immunological rejuvenation in people. As a result, he concluded that the drug could be used to increase longevity in people.
The drug is also used to treat Alzheimer, muscular dystrophy and SLE.Blagosklonny extensive research on oncology has helped him to uncover better ways of targeting cancer. His idea is to bring a long lasting solution that will be accessible even to the low economically empowered people. As a result, Mikhail medical research puts focus on cancer and aging as the two diseases interact at a particular stage. Most importantly, he nurtures and contributes to the development of students whose aim is to grow, expand, and help the world of oncology. Most of his research has got attention both in the medical field and research fields. Mikhail acknowledges that the present methods of treating cancer are excruciating and expensive. Today, he researches on ways of eliminating cancer cells from the body without harming the healthy cells. Such a breakthrough would result in a low mortality that is caused by cancer.Mikhail has made advancements in his research and hopes to inspire researchers into continuing with his remarkable work. Still, he believes in the eradication of the disease. With time, cancer will be treated easily with regular drugs.